CLINICAL_TRIALS
trial_result
· 2024-05-10
Clinical Trial Update: The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)
Summary
Completed clinical validation of fractionated exhaled nitric oxide for diagnosing and assessing disease activity in eosinophilic esophagitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The University of Texas Health Science Center, Houston | Conditions: Eosinophilic Esophagitis | Status: COMPLETED